Proteomics: Technologies and Global Markets

Description

List of Tables

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

The North American market for proteomic technologies is projected to grow from $12.5 billion in 2025 to $23.6 billion by the end of 2030, at a CAGR of 13.6% from 2025 to 2030.

The Asia-Pacific market for proteomic technologies is projected to grow from $7.4 billion in 2025 to $15.0 billion by the end of 2030, at a CAGR of 15.0% from 2025 to 2030.

Report Scope

The report analyzes trends in the global market for proteomic technologies market. It includes global revenues ($ millions) for the base year of 2024, estimates for 2025 and forecasts for 2025 through 2030. The market is segmented by product type, application, platform and region. Protein structural analysis and protein-expression products are outside the scope of the report. Product types include instruments and software, and consumables. Platforms include mass spectrometry and biochip. Applications include drug discovery and development, research, diagnostics, and applied proteomics. Regions are North America, Europe, Asia-Pacific and the Rest of the World (RoW). North America includes the U.S., Canada and Mexico. Europe includes Germany, the U.K., Italy, France, Spain and the Rest of Europe; Asia-Pacific includes China, Japan, India, South Korea and the Rest of Asia-Pacific. RoW includes the Middle East and Africa (MEA) and South America.

The report focuses on the trends and challenges that affect the market and vendor landscape. It discusses emerging technologies and includes an analysis of the market shares of the leading companies. It offers a chapter on environmental, social, and corporate governance (ESG) developments. Its section on company profiles covers details such as financials, product portfolio, and recent developments.

Report Includes

97 data tables and 56 additional tables
An overview of the global markets for proteomics and related technologies
Analyses of the global market trends, with historic market revenue data from 2022 to 2024, estimates for 2025 and projected CAGRs through 2030
Estimates of the actual market size and forecasts for proteomics, and a corresponding market share analysis by platform type, application, product type, and region
In-depth facts and figures concerning market dynamics, technology advances, new products and applications for proteomics
Discussion of patents and emerging technologies
ESG trends in the industry
Insight into the industry structure for proteomics technologies, competitive aspects of each product segment, companies' growth strategies, and a company value share analysis
Updated information on mergers and acquisitions, agreements, partnerships and new products in the global proteomics industry
Profiles of the leading companies, including Thermo Fisher Scientific Inc., Danaher, Agilent Technologies Inc., Bruker and Waters Corp.

Product Code: BIO034G

Chapter 1 Executive Summary

Market Outlook
Scope of Report
Market Summary
Overview
Current Market Scenario
Segmental Analysis
Regional Analysis
Emerging Technologies
Conclusion

Chapter 2 Market Overview

Proteomic Technologies
Types of Proteomics
Expression Proteomics
Structural Proteomics
Functional Proteomics
Proteomics Workflow
Macroeconomic Factors Analysis
Porter's Five Forces Analysis
Bargaining Power of Buyers
Bargaining Power of Suppliers
Threat of Substitute Products or Services
Potential for New Entrants
Industry Competitiveness

Chapter 3 Market Dynamics

Market Dynamics
Market Drivers
Investments in R&D
Transition To Personalized Medicines
Rising Aging Population and the Growing Prevalence of Chronic Diseases
Market Restraints
High Cost of Instruments and Lack of Skilled Workforce
Complexity of Data Analysis
Market Opportunities
Emerging Technologies
Integrative Approaches

Chapter 4 Regulatory Landscape

Regulatory Overview
Regulations in the U.S.
Regulations in Europe
Proteomics Standards Initiative

Chapter 5 Emerging Technologies and Developments

Emerging Technologies in the Proteomics Market
Advances in Mass Spectrometry
Immuno-Ligation
Single-cell Proteomics
Application of AI in Proteomics
Patent Analysis
Patents, by Top Applicants
Patents, by Assignee Country/Region
Patents, by Year
Key Takeaways

Chapter 6 Market Segmentation Analysis

Overview
Segmentation Breakdown
Market Analysis by Platform Type
Mass Spectrometry
Biochips
Market Analysis by Application
Takeaways
Drug Discovery and Development
Diagnostics
Research
Applied Proteomics
Market Analysis by Product Type
Takeaways
Consumables
Instruments and Software
Geographic Breakdown
Market Analysis by Region
Takeaways
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 Competitive Intelligence

Overview
Market Ranking Analysis
Strategic Initiatives
Mergers and Acquisitions
Agreements, Collaborations and Partnerships
New Products

Chapter 8 Sustainability in the Proteomics Technology Industry: ESG Perspective

Introduction to Environmental, Social and Governance
Sustainability Trends and Initiatives
Environmental Performance
Social Performance
Governance Performance
ESG Risk Ratings
Concluding Remarks from BCC Research

Chapter 9 Appendix

Methodology
Sources
Abbreviations
Company Profiles
AGILENT TECHNOLOGIES INC.
ARRAYIT CORP.
BIO-RAD LABORATORIES INC.
BIO-TECHNE
BRUKER
CREATIVE PROTEOMICS
DANAHER CORP.
JEOL LTD.
MERCK KGAA
PROMEGA CORP.
REVVITY
SHIMADZU CORP.
STANDARD BIOTOOLS
THERMO FISHER SCIENTIFIC INC.
WATERS CORP.
Emerging Start-ups/Market Disruptors

Product Code: BIO034G

List of Tables

Summary Table : Global Market for Proteomic Technologies, by Region, Through 2030
Table 1 : Global Incidence and Mortality Rates of Cancer, by Region, 2022
Table 2 : Granted Patents in Proteomics Technologies, 2023-2025
Table 3 : Global Market for Proteomics Technologies, by Platform Type, Through 2030
Table 4 : Global Market for Mass Spectrometry, by Region, Through 2030
Table 5 : Global Market for Biochips, by Type, Through 2030
Table 6 : Global Market for Protein Microarrays, by Array Type, Through 2030
Table 7 : Global Market for Biochips, by Region, Through 2030
Table 8 : Global Market for Proteomic Technologies, by Application Type, Through 2030
Table 9 : Drug Targets Identified by Proteomics
Table 10 : Global Market for Proteomics in Drug Discovery and Development, by Platform Type, Through 2030
Table 11 : Global Market for Proteomics in Drug Discovery and Development, by Region, Through 2030
Table 12 : Examples of LC-MS/MS-based FDA-Approved Tests in Clinical Laboratories
Table 13 : Global Market for Proteomics in Diagnostics, by Platform Type, Through 2030
Table 14 : Global Market for Proteomics in Diagnostics, by Region, Through 2030
Table 15 : Global Market for Proteomics in Diagnostics, by Disease Type, Through 2030
Table 16 : Global Market for Proteomics in Research, by Platform Type, Through 2030
Table 17 : Global Market for Proteomics in Research, by Region, Through 2030
Table 18 : Global Market for Applied Proteomics, by Region, Through 2030
Table 19 : Global Market for Proteomic Technologies, by Product Type, Through 2030
Table 20 : Global Market for Consumables, by Region, Through 2030
Table 21 : Global Market for Instruments and Software, by Region, Through 2030
Table 22 : Global Market for Proteomic Technologies, by Region, Through 2030
Table 23 : North American Market for Proteomic Technologies, by Platform Type, Through 2030
Table 24 : North American Market for Biochips, by Type, Through 2030
Table 25 : North American Market for Proteomic Technologies, by Application Type, Through 2030
Table 26 : North American Market for Proteomic Technologies, by Product Type, Through 2030
Table 27 : North American Market for Proteomic Technologies, by Country, Through 2030
Table 28 : U.S. Market for Proteomic Technologies, by Platform Type, Through 2030
Table 29 : U.S. Market for Proteomic Technologies, by Application Type, Through 2030
Table 30 : U.S. Market for Proteomic Technologies, by Product Type, Through 2030
Table 31 : Canadian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 32 : Canadian Market for Proteomic Technologies, by Application Type, Through 2030
Table 33 : Canadian Market for Proteomic Technologies, by Product Type, Through 2030
Table 34 : Mexican Market for Proteomic Technologies, by Platform Type, Through 2030
Table 35 : Mexican Market for Proteomic Technologies, by Application Type, Through 2030
Table 36 : Mexican Market for Proteomic Technologies, by Product Type, Through 2030
Table 37 : European Market for Proteomic Technologies, by Platform Type, Through 2030
Table 38 : European Market for Biochips, by Type, Through 2030
Table 39 : European Market for Proteomic Technologies, by Application Type, Through 2030
Table 40 : European Market for Proteomic Technologies, by Product Type, Through 2030
Table 41 : European Market for Proteomic Technologies, by Country, Through 2030
Table 42 : German Market for Proteomic Technologies, by Platform Type, Through 2030
Table 43 : German Market for Proteomic Technologies, by Application Type, Through 2030
Table 44 : German Market for Proteomic Technologies, by Product Type, Through 2030
Table 45 : U.K. Market for Proteomic Technologies, by Platform Type, Through 2030
Table 46 : U.K. Market for Proteomic Technologies, by Application Type, Through 2030
Table 47 : U.K. Market for Proteomic Technologies, by Product Type, Through 2030
Table 48 : French Market for Proteomic Technologies, by Platform Type, Through 2030
Table 49 : French Market for Proteomic Technologies, by Application Type, Through 2030
Table 50 : French Market for Proteomic Technologies, by Product Type, Through 2030
Table 51 : Italian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 52 : Italian Market for Proteomic Technologies, by Application Type, Through 2030
Table 53 : Italian Market for Proteomic Technologies, by Product Type, Through 2030
Table 54 : Spanish Market for Proteomic Technologies, by Platform Type, Through 2030
Table 55 : Spanish Market for Proteomic Technologies, by Application Type, Through 2030
Table 56 : Spanish Market for Proteomic Technologies, by Product Type, Through 2030
Table 57 : Rest of European Market for Proteomic Technologies, by Platform Type, Through 2030
Table 58 : Rest of European Market for Proteomic Technologies, by Application Type, Through 2030
Table 59 : Rest of European Market for Proteomic Technologies, by Product Type, Through 2030
Table 60 : Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
Table 61 : Asia-Pacific Market for Biochips, by Type, Through 2030
Table 62 : Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
Table 63 : Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
Table 64 : Asia-Pacific Market for Proteomic Technologies, by Country, Through 2030
Table 65 : Chinese Market for Proteomic Technologies, by Platform Type, Through 2030
Table 66 : Chinese Market for Proteomic Technologies, by Application Type, Through 2030
Table 67 : Chinese Market for Proteomic Technologies, by Product Type, Through 2030
Table 68 : Japanese Market for Proteomic Technologies, by Platform Type, Through 2030
Table 69 : Japanese Market for Proteomic Technologies, by Application Type, Through 2030
Table 70 : Japanese Market for Proteomic Technologies, by Product Type, Through 2030
Table 71 : Indian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 72 : Indian Market for Proteomic Technologies, by Application Type, Through 2030
Table 73 : Indian Market for Proteomic Technologies, by Product Type, Through 2030
Table 74 : South Korean Market for Proteomic Technologies, by Platform Type, Through 2030
Table 75 : South Korean Market for Proteomic Technologies, by Application Type, Through 2030
Table 76 : South Korean Market for Proteomic Technologies, by Product Type, Through 2030
Table 77 : Australian Market for Proteomic Technologies, by Platform Type, Through 2030
Table 78 : Australian Market for Proteomic Technologies, by Application Type, Through 2030
Table 79 : Australian Market for Proteomic Technologies, by Product Type, Through 2030
Table 80 : Rest of Asia-Pacific Market for Proteomic Technologies, by Platform Type, Through 2030
Table 81 : Rest of Asia-Pacific Market for Proteomic Technologies, by Application Type, Through 2030
Table 82 : Rest of Asia-Pacific Market for Proteomic Technologies, by Product Type, Through 2030
Table 83 : RoW Market for Proteomic Technologies, by Platform Type, Through 2030
Table 84 : RoW Market for Proteomic Technologies, by Application Type, Through 2030
Table 85 : RoW Market for Biochips, by Type, Through 2030
Table 86 : RoW Market for Proteomic Technologies, by Product Type, Through 2030
Table 87 : RoW Market for Proteomic Technologies, by Sub-region, Through 2030
Table 88 : Rank of Manufacturers in the Proteomics Technology Market, 2024
Table 89 : Mergers and Acquisitions in the Proteomics Technology Industry, 2020-2025
Table 90 : Agreements, Collaborations and Partnerships in the Proteomics Technology Industry, 2022-2025
Table 91 : Product Introductions in the Proteomics Technology Market, 2023-2025
Table 92 : Environmental Performance Initiatives in the Proteomics Industry
Table 93 : Social Performance Initiatives in Proteomics Market
Table 94 : Governance Performance Initiatives in the Proteomics Industry
Table 95 : ESG Rankings for Proteomics Companies, 2025*
Table 96 : Information Sources for this Report
Table 97 : Abbreviations Used in this Report
Table 98 : Agilent Technologies Inc.: Company Snapshot
Table 99 : Agilent Technologies Inc.: Financial Performance, FY 2023 and 2024
Table 100 : Agilent Technologies Inc.: Product Portfolio
Table 101 : Agilent Technologies Inc: News/Key Developments, 2023 and 2024
Table 102 : Arrayit Corp.: Company Snapshot
Table 103 : Arrayit Corp.: Product Portfolio
Table 104 : Bio-Rad Laboratories Inc.: Company Snapshot
Table 105 : Bio-Rad Laboratories Inc.: Financial Performance, FY 2023 and 2024
Table 106 : Bio-Rad Laboratories Inc.: Product Portfolio
Table 107 : Bio-Rad Laboratories Inc.: News/Key Developments, 2021 and 2023
Table 108 : Bio-Techne: Company Snapshot
Table 109 : Bio-Techne: Financial Performance, FY 2022 and 2023
Table 110 : Bio-Techne: Product Portfolio
Table 111 : Bio-Techne: News/Key Developments, 2024 and 2025
Table 112 : Bruker: Company Snapshot
Table 113 : Bruker: Financial Performance, FY 2023 and 2024
Table 114 : Bruker: Product Portfolio
Table 115 : Bruker: News/Key Developments, 2022-2025
Table 116 : Creative Proteomics: Company Snapshot
Table 117 : Creative Proteomics: Product Portfolio
Table 118 : Danaher Corp.: Company Snapshot
Table 119 : Danaher Corp.: Financial Performance, FY 2023 and 2024
Table 120 : Danaher Corp.: Product Portfolio
Table 121 : Danaher Corp.: News/Key Developments, 2024
Table 122 : JEOL Ltd.: Company Snapshot
Table 123 : JEOL Ltd.: Financial Performance, FY 2022 and 2023
Table 124 : JEOL Ltd.: Product Portfolio
Table 125 : JEOL Ltd.: News/Key Developments, 2023
Table 126 : Merck KGaA: Company Snapshot
Table 127 : Merck KGaA: Financial Performance, FY 2023 and 2024
Table 128 : Merck KGaA: Product Portfolio
Table 129 : Merck KGaA: News/Key Developments, 2023 and 2024
Table 130 : Promega Corp.: Company Snapshot
Table 131 : Promega Corp.: Product Portfolio
Table 132 : Revvity: Company Snapshot
Table 133 : Revvity: Financial Performance, FY 2023 and 2024
Table 134 : Revvity: Product Portfolio
Table 135 : Revvity: News/Key Developments, 2023 and 2024
Table 136 : Shimadzu Corp.: Company Snapshot
Table 137 : Shimadzu Corp.: Financial Performance, FY 2022 and 2023
Table 138 : Shimadzu Corp.: Product Portfolio
Table 139 : Shimadzu Corp.: News/Key Developments, 2024 and 2025
Table 140 : Standard BioTools: Company Snapshot
Table 141 : Standard BioTools: Financial Performance, FY 2023 and 2024
Table 142 : Standard BioTools: Product Portfolio
Table 143 : Standard BioTools: News/Key Developments, 2024
Table 144 : Thermo Fisher Scientific Inc.: Company Snapshot
Table 145 : Thermo Fisher Scientific Inc.: Financial Performance, FY 2023 and 2024
Table 146 : Thermo Fisher Scientific Inc.: Product Portfolio
Table 147 : Thermo Fisher Scientific Inc.: News/Key Developments, 2022-2025
Table 148 : Waters Corp.: Company Snapshot
Table 149 : Waters Corp.: Financial Performance, FY 2023 and 2024
Table 150 : Waters Corp.: Product Portfolio
Table 151 : Waters Corp.: News/Key Developments, 2023 and 2024
Table 152 : Emerging Startups in the Global Proteomics Market

List of Figures

Summary Figure : Share of Global Market for Proteomic Technologies, by Region, 2024
Figure 1 : Bottom-Up and Top-Down Proteomics
Figure 2 : Porter's Five Forces Analysis of the Market for Proteomic Technologies
Figure 3 : Market Dynamics for Proteomics Technologies
Figure 4 : Average Venture Funding for Biopharma Therapeutics and Platform Companies, 2010-2024
Figure 5 : Pharmaceutical R&D Expenditures for the U.S., Europe, Japan and China, for 2010, 2020 and 2022
Figure 6 : Personalized Medicines and All FDA Approvals, 2015-2023
Figure 7 : Patents Related to Proteomics, by Applicant, 2021-March 2025
Figure 8 : Share of Patents Related to Proteomics, by Country/Region, 2021-March 2025
Figure 9 : Patents Related to Proteomics, by Year, 2010-March 2025
Figure 10 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024
Figure 11 : Share of Global Market for Proteomics Technologies, by Application Type, 2024
Figure 12 : Share of Global Market for Proteomics Technologies, by Platform Type, 2024
Figure 13 : Share of Global Market for Proteomic Technologies, by Region, 2024
Figure 14 : Share of North American Market for Proteomic Technologies, by Country, 2024
Figure 15 : NIH Funding in Healthcare R&D, 2010-2023
Figure 16 : Share of European Market for Proteomic Technologies, by Country, 2024
Figure 17 : Share of Asia-Pacific Market for Proteomic Technologies, by Country, 2024
Figure 18 : Share of RoW Market for Proteomic Technologies, by Sub-region, 2024
Figure 19 : Agilent Technologies Inc.: Revenue Share, by Business Unit, FY 2024
Figure 20 : Agilent Technologies Inc.: Revenue Share, by Country/Region, FY 2024
Figure 21 : Bio-Rad Laboratories Inc.: Revenue Share, by Business Unit, FY 2024
Figure 22 : Bio-Rad Laboratories Inc.: Revenue Share, by Country/Region, FY 2024
Figure 23 : Bio-Techne: Revenue Share, by Business Unit, FY 2023
Figure 24 : Bio-Techne: Revenue Share, by Country/Region, FY 2023
Figure 25 : Bruker: Revenue Share, by Business Unit, FY 2024
Figure 26 : Bruker: Revenue Share, by Country/Region, FY 2024
Figure 27 : Danaher Corp.: Revenue Share, by Business Unit, FY 2024
Figure 28 : Danaher Corp.: Revenue Share, by Country/Region, FY 2024
Figure 29 : JEOL Ltd.: Revenue Share, by Business Unit, FY 2023
Figure 30 : JEOL Ltd.: Revenue Share, by Country/Region, FY 2023
Figure 31 : Merck KGaA: Revenue Share, by Business Unit, FY 2024
Figure 32 : Merck KGaA: Revenue Share, by Country/Region, FY 2024
Figure 33 : Revvity: Revenue Share, by Business Unit, FY 2024
Figure 34 : Revvity: Revenue Share, by Country/Region, FY 2024
Figure 35 : Shimadzu Corp.: Revenue Share, by Business Unit, FY 2023
Figure 36 : Shimadzu Corp.: Revenue Share, by Country/Region, FY 2023
Figure 37 : Standard BioTools: Revenue Share, by Business Unit, FY 2024
Figure 38 : Standard BioTools: Revenue Share, by Country/Region, FY 2024
Figure 39 : Thermo Fisher Scientific Inc.: Revenue Share, by Business Unit, FY 2024
Figure 40 : Thermo Fisher Scientific Inc.: Revenue Share, by Country/Region, FY 2024
Figure 41 : Waters Corp.: Revenue Share, by Business Unit, FY 2024
Figure 42 : Waters Corp.: Revenue Share, by Country/Region, FY 2024

Proteomics: Technologies and Global Markets

Description

Table of Contents

List of Tables

Report Scope

Report Includes

Table of Contents

Chapter 1 Executive Summary

Chapter 2 Market Overview

Chapter 3 Market Dynamics

Chapter 4 Regulatory Landscape

Chapter 5 Emerging Technologies and Developments

Chapter 6 Market Segmentation Analysis

Chapter 7 Competitive Intelligence

Chapter 8 Sustainability in the Proteomics Technology Industry: ESG Perspective

Chapter 9 Appendix

List of Tables

List of Figures